Xeris Biopharma Holdings Inc
(FRA:2B30)
€
1.839
-0.002 (-0.11%)
Market Cap: 289.37 Mil
Enterprise Value: 457.12 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 67/100 Xeris Biopharma Holdings Inc (FRA:2B30) Transcripts
- Q4 2023 Xeris Biopharma Holdings Inc Earnings Call TranscriptMar 06, 2024€2.7 (-2.17%)Earnings
- Xeris Biopharma Holdings Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Xeris Biopharma Holdings Inc Earnings Call TranscriptNov 09, 2023€1.82 (+5.20%)Earnings
- Q2 2023 Xeris Biopharma Holdings Inc Earnings Call TranscriptAug 08, 2023€2.22 (-6.72%)Earnings
- Q1 2023 Xeris Biopharma Holdings Inc Earnings Call TranscriptMay 09, 2023€2.14Earnings
- Q4 2022 Xeris Biopharma Holdings Inc Earnings Call TranscriptMar 08, 2023€1.41 (+5.95%)Earnings
- Xeris Biopharma Holdings Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- Q3 2022 Xeris Biopharma Holdings Inc Earnings Call TranscriptNov 09, 2022€1.46 (-2.70%)Earnings
- Xeris Biopharma Holdings Inc XP-8121 Call TranscriptOct 20, 2022
- Q2 2022 Xeris Biopharma Holdings Inc Earnings Call TranscriptAug 10, 2022€1.64 (-8.14%)Earnings
- Q1 2022 Xeris Biopharma Holdings Inc Earnings Call TranscriptMay 11, 2022€1.67 (-2.68%)Earnings
- Q4 2021 Xeris Biopharma Holdings Inc Earnings Call TranscriptMar 10, 2022€2.2 (+1.85%)Earnings
- Q3 2021 Xeris Biopharma Holdings Inc Earnings Call TranscriptNov 10, 2021€1.67 (-2.79%)Earnings
- 1